You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

salvage%20autologous%20hematopoietic%20cell%20transplantation

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Houston (Belantamab mafodotin)

Recruiting
  • Multiple Myeloma
  • Belantamab mafodotin
  • Houston, Texas
    M D Anderson Cancer Center
Jan 5, 2023

Multiple Myeloma Trial in United States (Carfilzomib, Lenalidomide, Dexamethasone)

Active, not recruiting
  • Multiple Myeloma
  • Birmingham, Alabama
  • +11 more
Aug 11, 2022

Multiple Myeloma Trial in United States (Iberdomide)

Recruiting
  • Multiple Myeloma
  • Basking Ridge, New Jersey
  • +7 more
Jun 10, 2022

Beta-Thalassemia Trial (CS-101 injection)

Not yet recruiting
  • Beta-Thalassemia
  • CS-101 injection
  • (no location specified)
Sep 27, 2023

Non-interventional Study on Salvage Auto in Relapsed Myeloma

Completed
  • Relapsed Multiple Myeloma
    • Paris, France
      Hématologie Clinique, Hôpital Saint Antoine
    Jan 19, 2021

    Well-being of Caregivers (Caregiver Strain Index) Trial in Durham (home care)

    Recruiting
    • Well-being of Caregivers (Caregiver Strain Index)
    • home care
    • Durham, North Carolina
      Duke University Medical Center
    Jan 25, 2023

    Multiple Myeloma Trial in Wuhan (Total Marrow irradiation,TMI, Autologous hematopoietic stem cell transplantation)

    Recruiting
    • Multiple Myeloma
    • Total Marrow irradiation，TMI
    • Autologous hematopoietic stem cell transplantation
    • Wuhan, Hubei, China
      Zhongnan Hospital of Wuhan University
    Jul 24, 2023

    Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in

    Not yet recruiting
    • Systemic Sclerosis
    • SARS-CoV 2 Vaccination
      • (no location specified)
      Jul 24, 2023

      Engraftment Syndrome Trial (Budesonide)

      Not yet recruiting
      • Engraftment Syndrome
      • (no location specified)
      Aug 19, 2022

      ASCT Versus Chemotherapy as First-Line Consolidation Therapy

      Completed
      • T-cell Lymphoma Adults
      • consolidation with ASCT
      • (no location specified)
      Nov 25, 2023

      Multiple Myeloma Trial in Tampa (Selinexor, Melphalan, Dexamethasone)

      Completed
      Has Results
      • Multiple Myeloma
      • Tampa, Florida
        H. Lee Moffitt Cancer Center and Research Institute
      Nov 2, 2022

      Lymphoma, Peripheral Blood Stem Cell Transplantation Trial (Eltrombopag olamine)

      Not yet recruiting
      • Lymphoma
      • Peripheral Blood Stem Cell Transplantation
      • Eltrombopag olamine
      • (no location specified)
      Jul 25, 2023

      Lymphoma Trial in Cairo (BEAM Protocol, CEM protocol)

      Recruiting
      • Lymphoma
      • BEAM Protocol
      • CEM protocol
      • Cairo, Egypt
        International Medical Center (IMC) Hospital, Cairo, Egypt.
      Apr 1, 2023

      Multiple Myeloma, Lymphoma, Engagement, Patient Trial (Grastofil®, Lapelga)

      Not yet recruiting
      • Multiple Myeloma
      • +3 more
      • (no location specified)
      Oct 30, 2023

      Taste Function In Multiple Myeloma Patients Undergoing

      Active, not recruiting
      • Multiple Myeloma
      • Oral microbiota assessment
      • +3 more
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Jan 23, 2023

      Multiple Myeloma Trial in Tianjin (Autologous hematopoietic stem cell transplantation, C-CAR088)

      Recruiting
      • Multiple Myeloma
      • Autologous hematopoietic stem cell transplantation
      • C-CAR088
      • Tianjin, Tianjin, China
        Institute of Hematology & Blood Diseases Hospital
      Nov 21, 2022

      Malignant Lymphoma, Multiple Myeloma Trial (Pentaisomaltose)

      Not yet recruiting
      • Malignant Lymphoma
      • Multiple Myeloma
      • Pentaisomaltose
      • (no location specified)
      Jan 5, 2023

      Sickle Cell Disease Trial in United States (biological, drug, genetic)

      Recruiting
      • Sickle Cell Disease
      • Plerixafor
      • +2 more
      • Oakland, California
      • +5 more
      Sep 13, 2022

      Hematopoietic Cell Transplantation (HCT) Trial (Tributyrin)

      Not yet recruiting
      • Hematopoietic Cell Transplantation (HCT)
      • Tributyrin
      • (no location specified)
      Jul 11, 2023

      Granulocyte Colony-Stimulating Factor Trial in Wuhan (PEG-rhG-CSF, G-CSF)

      Not yet recruiting
      • Granulocyte Colony-Stimulating Factor
      • Wuhan, Hubei, China
        Zhongnan Hospital of Wuhan University
      Jul 31, 2023

      Allogeneic Hematopoietic Stem Cell Trial in New York (fecal microbiota transplantation (FMT), No fecal microbiota

      Active, not recruiting
      • Allogeneic Hematopoietic Stem Cell
      • fecal microbiota transplantation (FMT)
      • No fecal microbiota transplantation (FMT), routine management
      • New York, New York
        Memorial Sloan Kettering Cancer Center
      Jul 25, 2022

      Plasma Cell Leukemia, Plasmacytoma, Recurrent Plasma Cell Myeloma Trial in Houston (procedure, drug, other)

      Active, not recruiting
      • Plasma Cell Leukemia
      • +3 more
      • Autologous Hematopoietic Stem Cell Transplantation
      • +7 more
      • Houston, Texas
        M D Anderson Cancer Center
      Oct 6, 2022

      Haploidentical Hematopoietic Stem Cell Transplantation Trial in Seoul (ATG-LDPTCy)

      Recruiting
      • Haploidentical Hematopoietic Stem Cell Transplantation
      • Seoul, Korea, Republic of
        Samsung Medical Center
      Sep 11, 2023

      Plasma Cell Myeloma Trial in Omaha (drug, procedure, biological)

      Active, not recruiting
      • Plasma Cell Myeloma
      • Omaha, Nebraska
        University of Nebraska Medical Center
      Nov 21, 2022

      Multiple Myeloma Trial in Hangzhou (BCMA CAR-T cells injection)

      Recruiting
      • Multiple Myeloma
      • BCMA CAR-T cells injection
      • Hangzhou, Zhejiang, China
        The first affiliated hospital of medical college of zhejiang uni
      Feb 13, 2023